COMMUNIQUÉS West-GlobeNewswire

Sarepta Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

30/06/2018 - 00:00

CAMBRIDGE, Mass., June 29, 2018 (GLOBE NEWSWIRE) -- Sarepta Therapeutics, Inc. (NASDAQ:SRPT), a commercial-stage biopharmaceutical company focused on the discovery and development of precision genetic medicine to treat [...]

Neon Therapeutics Announces Closing of Initial Public Offering

29/06/2018 - 22:15

CAMBRIDGE, Mass., June 29, 2018 (GLOBE NEWSWIRE) -- Neon Therapeutics, Inc. (Nasdaq:NTGN), a clinical-stage immuno-oncology company developing neoantigen-based therapeutics, today announced the closing of its initial [...]

Acura Pharmaceuticals Announces First Quarter 2018 Financial Results

29/06/2018 - 22:10

PALATINE, Ill., June 29, 2018 (GLOBE NEWSWIRE) -- Acura Pharmaceuticals, Inc. (OTC PINK:ACUR), a specialty pharmaceutical company innovating abuse deterrent drugs, announced today financial results for the three months [...]

TESARO Draws $200 Million From Second Tranche of Non-Dilutive Term Loan Financing

29/06/2018 - 22:05

WALTHAM, Mass., June 29, 2018 (GLOBE NEWSWIRE) -- TESARO, Inc. (NASDAQ:TSRO), an oncology focused biopharmaceutical company, announced today that it has drawn the $200 million second tranche under its term loan [...]

Aeglea BioTherapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

29/06/2018 - 22:00

AUSTIN, Texas, June 29, 2018 (GLOBE NEWSWIRE) -- Aeglea BioTherapeutics, Inc. (NASDAQ:AGLE), a clinical-stage biotechnology company that designs and develops innovative human enzyme therapeutics for patients with rare [...]

RavenQuest Lists Warrants

29/06/2018 - 20:59

VANCOUVER, British Columbia, June 29, 2018 (GLOBE NEWSWIRE) -- RavenQuest BioMed Inc. (CSE:RQB) (OTCQB:RVVQF) (Frankfurt:1IT) ( “ RavenQuest ”) is pleased to announce that warrants issued pursuant to its February 28, [...]

Leading International CBD Brand Gears Up to Go Public -- CFN Media

29/06/2018 - 20:34

Seattle, WA , June 29, 2018 (GLOBE NEWSWIRE) -- CFN Media Group (“CFN Media”), the leading agency and financial media network dedicated to the North American cannabis industry, today announced publication of an article [...]

New Alliance Seeks to Promote Health and Prevent Illness by Addressing Social Determinants of Health in Ogden, St. George

29/06/2018 - 18:51

Intermountain Healthcare involves city, county, and state government agencies and other community based organizations to come together to promote health, improve health care access, and decrease health care costs. Salt [...]

News Release: Essilor and Delfin extend the deadline of the Combination Agreement - EssilorLuxottica General Meeting to be reconvened

29/06/2018 - 18:46

Essilor and Delfin extend the deadline of the Combination Agreement EssilorLuxottica General Meeting to be reconvened PDF version of the news release Charenton-le-Pont, France, and Milan, Italy, ( June 29, 2018 ) - [...]

Communiqué: Essilor et Delfin prolongent le terme de l'accord de rapprochement - Report de l'Assemblée Générale d'EssilorLuxottica

29/06/2018 - 18:46

Essilor et Delfin prolongent le terme de l'accord de rapprochement Report de l'Assemblée Générale d'EssilorLuxottica Version PDF du communiqué Charenton-le-Pont, France et Milan, Italie (le 29 juin 2018) - Essilor et [...]

Kalytera Announces Appointment of Victoria Rudman as Interim Chief Financial Officer and Additional Payments in Shares under Payments Agreements with Salzman Group

29/06/2018 - 17:31

SAN FRANCISCO and TEL AVIV, Israel, June 29, 2018 (GLOBE NEWSWIRE) -- Kalytera Therapeutics, Inc. (TSX VENTURE:KALY) (OTCQB:KALTF) (the " Company " or " Kalytera ") today announced the appointment of Victoria Rudman as [...]

BLVD Centers Posts Audited Financial Statements for Period Ending February 28, 2018

29/06/2018 - 17:20

NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES LOS ANGELES, June 29, 2018 (GLOBE NEWSWIRE) -- BLVD Centers Corporation (“ BLVD ” or the “ Company ”) (CSE:BLVD), today [...]

HuMax®-AXL-ADC Progress Triggers Milestone Payment to Seattle Genetics

29/06/2018 - 16:19

Company Announcement Genmab to pay Seattle Genetics, Inc. a milestone payment of USD 7 million under the Antibody-Drug Conjugate (ADC) program targeting AXL Milestone triggered by clinical progress in the Phase I/II [...]

Alzheimer’s Foundation of America’s Statement on Senate Appropriations Committee Approval of FY 2019 Funding Increase for Alzheimer’s Disease Research

29/06/2018 - 16:10

NEW YORK, June 29, 2018 (GLOBE NEWSWIRE) -- The Senate Appropriations Committee approved a package that includes a $425 million increase in funding for Alzheimer’s disease research at the National Institutes of Health ( [...]

Innovation Pharmaceuticals Announces Database Lock for Phase 2b Trial of Oral Prurisol for Psoriasis

29/06/2018 - 16:00

BEVERLY, Mass., June 29, 2018 (GLOBE NEWSWIRE) -- Innovation Pharmaceuticals (OTCQB:IPIX) (“the Company”), a clinical stage biopharmaceutical company, today announces database lock for its Phase 2b clinical trial of [...]

RavenQuest Eyes Massive Micro Cultivation Market -- CFN Media

29/06/2018 - 15:00

SEATTLE, June 29, 2018 (GLOBE NEWSWIRE) -- CFN Media Group (“CFN Media”), the leading agency and financial media network dedicated to the North American cannabis industry, today announced publication of an article [...]

Newly Public, James E. Wagner Cultivation Moves Toward Cannabis Oils -- CFN Media

29/06/2018 - 15:00

SEATTLE, June 29, 2018 (GLOBE NEWSWIRE) -- CFN Media Group (“CFN Media”), the leading agency and financial media network dedicated to the North American cannabis industry, announces publication of an article discussing [...]

Ultragenyx Announces Positive CHMP Opinion for Mepsevii™ (vestronidase alfa) For the Treatment of Mucopolysaccharidosis VII

29/06/2018 - 15:00

NOVATO, Calif., June 29, 2018 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE) today announced that the Committee for Medicinal Products for Human Use (CHMP), the scientific committee of the European [...]

Devonian Announces Grant of Options

29/06/2018 - 14:45

QUEBEC CITY, June 29, 2018 (GLOBE NEWSWIRE) -- Devonian Health Group Inc. (" Devonian " or the " Corporation ") (TSX VENTURE:GSD) announces that the Board of Directors has approved the grant of options (the ‘‘Options [...]